Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II
AssigneeBehringwerke Aktiengesellschaft
InventorsBernard Knapp, Erika Hundt, Burkhard Enders, Hans Kupper
Life of this patent
Estimating the term…
Abstract
Recombinant histidine-rich protein of Plasmodium falciparum, its preparation and use. It was possible, by screening two different Plasmodium falciparum cDNA gene banks with an antiserum against a 41 kD protein and by cross-hybridization with the insert DNA of a clone obtained therewith, to isolate a gene which codes for a Histidine-Alanine-rich protein (HRP-II). This protein protects aotus monkeys from infection with P. falciparum and is thus a suitable constituent of a malaria vaccine.
Claims2
A method of inducing partial immunological protection against P. falciparum blood stage infection in a patient, comprising administering an isolated or purified HRP-II antigen of P. falciparum comprising the amino acid sequence as shown in Table 2 in the form of a vaccine in an amount sufficient to reduce the severity of infection by P. falciparum.
A vaccine comprising a pharmaceutically acceptable adjuvant and an isolated or purified P. falciparum HRP-II antigen, wherein said antigen comprises the following amino acid sequence:
- ##STR46##
Dependencies are inferred from the claim text.